ABBASI MEDICS LIMITED
- · Thesis: well-run, low negotiation leverage
Opportunity 80/100 (exceptional), bankability 75/100. Strong seller-intent signal (70/100, director aged 63). Share purchase looks the cleaner deal structure. Most likely exit: share sale to pe / searcher (73/100).
Data confidence
Overall: high (80/100)Strong data coverage across all sections. AI outputs should be trusted with minimal caveats.
Strong composite across quality, acquirability, and risk. High-priority target — progress to serious diligence.
Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2025-06-30 | 2024-06-30 |
|---|
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
Corporate timeline (18 events)Click to expand
- 2025-11-01📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-08-11📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-03-18📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2023-03-21📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2022-02-03📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2021-09-02📄notification-of-a-person-with-significant-controlpersons-with-significant-control · PSC01
- 2021-07-27📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2020-03-18📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2019-09-03📄gazette-filings-brought-up-to-dategazette · DISS40
- 2019-08-27📄gazette-notice-compulsorygazette · GAZ1
- 2019-02-25📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2018-07-30📄notification-of-a-person-with-significant-controlpersons-with-significant-control · PSC01
- 2018-03-08📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2017-03-08📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2016-09-07📄gazette-filings-brought-up-to-dategazette · DISS40
- 2009-06-05🏢Company incorporatedAs ABBASI MEDICS LIMITED
- 2009-06-05➕ABBASI, Ayaz, Dr appointeddirector
- 2009-06-05➕AYAZ, Sumra appointeddirector
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
- +Founder name in company name: Company name contains director surname "ABBASI" — strong identity link between founder and business.
- +Long-tenure founder: Senior director has been in place 17 years — deep operational knowledge concentrated in one person.
- +Senior director age: Director aged approximately 63 — approaching natural succession window.
- +No director turnover: Company is 17 years old with no director changes — suggests a very tight-knit founder team never broadened.
Succession & seller-readiness
Strong acquirability signals converging. Worth approaching directly — this is how off-market deals start.
- primaryFounder aged 63+: Senior director is approximately 63. Approaching typical UK retirement age — succession thinking likely.
- secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
- secondary12+ year tenure: Director in role 17 years.
- secondaryStable-but-static management: Company is 17 years old and no new directors in the last 3 years — succession not yet being planned internally.
- supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.
Red flags
cleanShareholders & ownership
2 active beneficial owners| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Dr Ayaz Abbasi Individual · British · DOB 06/1963 · age 63 | 25–50% | 25–50% | 25-50% shares · 25-50% voting | 02/09/2021 |
Mrs Sumra Ayaz Individual · British · DOB 08/1966 · age 60 | 25–50% | — | 25-50% shares | 30/07/2018 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Healthcare & medical · BL postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| "A" CERAMICS LIMITED→ 04494986 · est 2002 · no financials extracted | — | — | — | — | 23y | — | — |
| 360 HEALTHCARE HUB LTD→ 15573210 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| A BUTT PHYSIOTHERAPY LIMITED→ 04194870 · est 2001 · no financials extracted | — | — | — | — | 25y | — | — |
| AA HEALTH LTD→ 11032069 · est 2017 · no financials extracted | — | — | — | — | 8y | — | — |
| AA INNOVATIONS LTD→ 14562393 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| AA LOCUM SERVICES (UK) LIMITED→ 07621123 · est 2011 · no financials extracted | — | — | — | — | 14y | — | — |
| AARIF GIJA CO LTD→ 12291222 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| AB IMAGING SERVICES LIMITED→ 14773908 · est 2023 · no financials extracted | — | — | — | — | 3y | — | — |
| ABBEYWOOD (TOTTINGTON) LIMITED→ 03606524 · est 1998 · no financials extracted | — | — | — | — | 27y | — | — |
| ABBIE CARE LIMITED→ 13061925 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| ABILITY CASE MANAGEMENT LIMITED→ 11922424 · est 2019 · no financials extracted | — | — | — | — | 7y | — | — |
| ABIODUN O.N LTD→ 14856405 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
6 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (2 active · 0 resigned)
Click a director name to see their full track record across all companies.